JosephPaulEderMD

Summary

• Dr. Joseph Eder, based in Boston, MA, is an oncologist with extensive training, having completed fellowships in medical oncology and hematology at Georgetown University Hospital, Beth Israel Deaconess Medical Center and Dana - Farber Cancer Institute. He graduated from Georgetown University School of Medicine in 1978 and completed his residency in internal medicine at MedStar Health/Georgetown University Hospital. He completed fellowships at Dana-Farber Cancer Institute and Beth Israel Hospital in Boston. He continued on faculty at BIH/BIDMC and DFCI and Harvard Medical School until 20012. He was Clinical Director of Developmental Therapeutics at DF/HCC from 1995 - 2007. Dr, Eder was Senior Director at Astra Zeneca 2007 - 2012. Dr. Eder was Clinical Director of Developmental therapeutics at Yale Cancer Center 2012-2022. Since November2022 he has been CMO at Incendia Therapeutics in Cambridge MA. Dr. Eder has expertise in clinical drug development, cancer pharmacology and precision medicine. He has been involved in numerous clinical trials and has > 125 original publications in oncology-related journals, including studies on small molecules, therapeutic antibodies, vaccines, financial toxicity, bispecific antibodies, and Precision Medicine.